4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Gain Therapeutics, Inc. (GANX) operates in the Biotechnology industry and is headquartered in Bethesda, United States with about 20 employees. Its market capitalization is roughly $77 million. In the fiscal year ended 2025-12-31, GANX reported $0M in revenue and ($20M) in net income.
Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($19M) | ($20M) | ($22M) | ($18M) | — |
| Net Income | ($20M) | ($20M) | ($22M) | ($18M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($5M) | ($4M) | ($5M) | ($5M) | ($4M) |
| Net Income | ($6M) | ($4M) | ($5M) | ($6M) | ($4M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $23M | $12M | $19M | $24M | — |
| Total Liabilities | $4M | $5M | $6M | $5M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GANX viewer.
About TickerBase · Data methodology & sources